Previous 10 | Next 10 |
2024-05-20 04:37:00 ET Investors looking to pad their passive income streams with high-yield dividend stocks have three excellent choices. If you have an extra $100 to invest, you could set yourself up with dividends from Realty Income (NYSE: O) , Altria Group (NYSE: MO) , o...
2024-05-19 15:05:03 ET More on Eli Lilly, Novo Nordisk, etc. Eli Lilly: Great Time To Divest Before It Potentially Crashes Eli Lilly Remains Expensive Here - Minimal Margin Of Safety The FTC Cracks Down On Novo Nordisk's Ozempic Biopharma M&A surges year ...
2024-05-18 14:52:07 ET More on GSK, Johnson & Johnson, etc. Shockwave Medical: A Look Into Q1 Financials And Value To Johnson & Johnson Investors Merck & Co., Inc. (MRK) BofA Securities 2024 Health Care Conference (Transcript) Johnson & Johnson (JNJ) ...
2024-05-17 21:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-05-17 13:25:19 ET More on Moderna Moderna Q1: A Promising Pipeline Is Undervalued Moderna, Inc. (MRNA) Q1 2024 Earnings Call Transcript Moderna, Inc. 2024 Q1 - Results - Earnings Call Presentation Evercore says biotech ‘winter is finally thawing...
2024-05-17 12:18:39 ET Summary Pfizer's earnings and sales have fallen due to decreased demand for COVID-19-related products, leading to a large selling pressure this year. The stock price has recently started rebounding from its low point and is showing bullish technical signs fo...
2024-05-16 23:00:27 ET Summary Pfizer's stock has struggled to recover since the pandemic, but its high dividend yield of 5.9% makes it an attractive option for income investors. The company faces risks from upcoming patent expiries and the impact of rising interest rates on its d...
2024-05-16 12:29:52 ET More on GSK, Haleon plc, etc. Haleon: Pressures Are Temporary, But Closer To Fair Value GSK plc (GSK) Q1 2024 Earnings Call Transcript Sales Call GSK expands collaboration with BioVersys on tuberculosis asset alpibectir GSK Non-...
2024-05-16 09:45:00 ET The healthcare industry is full of opportunities for long-term investors to become part-owner in compelling businesses that are changing the future for patients across countless disease areas. You don't have to be rich to invest in the stock market. Whether you're...
2024-05-16 09:00:00 ET Summary The combination of earnings season and a dovish Fed are pushing the markets closer to all-time highs. The Dividend Harvesting Portfolio has reached an all-time high in profitability and account value, with a 13.14% return on invested capital. The...
News, Short Squeeze, Breakout and More Instantly...
2024-07-22 05:59:00 ET Both Pfizer (NYSE: PFE) and Roche Holdings (OTC: RHHBY) rank among the world's most powerful pharmaceutical companies. Yet neither is actively competing in the all-important market for weight loss drugs, which is currently being split between the likes...
2024-07-20 10:00:00 ET On July 11, Pfizer (NYSE: PFE) made an announcement that came as a bit of a surprise to biopharma industry experts and Wall Street analysts alike. It's planning on advancing one of its early-stage weight loss programs into mid-stage trials. In due time, the mo...
2024-07-18 13:06:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...